Gardner Lewis Asset Management L P Sells 12,445 Shares of Humana Inc. (NYSE:HUM)

Gardner Lewis Asset Management L P lessened its position in shares of Humana Inc. (NYSE:HUM) by 56.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,670 shares of the insurance provider’s stock after selling 12,445 shares during the period. Gardner Lewis Asset Management L P’s holdings in Humana were worth $2,453,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the company. Orion Portfolio Solutions LLC lifted its stake in Humana by 3.7% in the fourth quarter. Orion Portfolio Solutions LLC now owns 4,834 shares of the insurance provider’s stock valued at $1,226,000 after buying an additional 171 shares during the period. denkapparat Operations GmbH bought a new stake in Humana in the 4th quarter valued at about $323,000. Pictet Asset Management Holding SA grew its stake in Humana by 18.8% in the fourth quarter. Pictet Asset Management Holding SA now owns 72,803 shares of the insurance provider’s stock valued at $18,471,000 after acquiring an additional 11,523 shares during the period. High Ground Investment Management LLP raised its position in shares of Humana by 43.5% during the fourth quarter. High Ground Investment Management LLP now owns 424,403 shares of the insurance provider’s stock worth $107,675,000 after purchasing an additional 128,636 shares during the period. Finally, New Age Alpha Advisors LLC bought a new stake in Humana during the 4th quarter valued at $2,960,000. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Shares of HUM opened at $270.04 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market cap of $32.59 billion, a PE ratio of 27.14, a PEG ratio of 2.05 and a beta of 0.57. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $406.46. The stock’s fifty day moving average price is $270.51 and its two-hundred day moving average price is $274.93.

Humana (NYSE:HUM) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.31%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares in the company, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.37% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. StockNews.com downgraded Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, March 18th. Morgan Stanley lowered their price target on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a research report on Wednesday, February 12th. JPMorgan Chase & Co. cut their price objective on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a report on Tuesday, February 18th. Piper Sandler upped their target price on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Finally, Truist Financial raised their price target on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research report on Monday, January 6th. Eighteen equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $285.68.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.